TP53 and neoplasm: Multiple oncogenic pathways, such as Ras-dependent, Myc or PI3K, favor glycolysis over oxidative phosphorylation, while many tumor suppressors such as p53, Von Hippel–Lindau (VHL), or liver kinase B1 (LKB1) negate the “Warburg effect” [48,49].